Glaucoma Drainage Devices Market to Reach USD1,300 Million by 2030 Due to Increasing Prevalence of Glaucoma

The Global Glaucoma Drainage Devices Market size was valued at around USD716 million in 2024 and is projected to reach USD1,300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.56% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The rising cases of glaucoma in the world are the major driving factor behind the demand for drainage devices for this problem. This eye disease accounts for being the second leading cause of blindness worldwide, and thus affected over 76 million people in 2020 and is estimated to reach 111 million cases by the year 2040. Glaucoma majorly affects the aging population, which is also rising globally, leading to an increase in demand for drainage devices as they lower intraocular pressure and help to preserve the optic nerve of the eye. Government initiatives and repayment plans are also enhancing the accessibility of glaucoma treatment.

Furthermore, greater awareness and early glaucoma diagnosis are improving treatment outcomes. The Global Glaucoma Awareness Program has significantly increased screening rates and helped with early disease detection due to the support of leading ophthalmology associations. Research institutions and medical device manufacturers are now collaborating to develop innovative treatment solutions. Glaucoma drainage devices and associated surgical procedures are very expensive, which is one of the main market barriers. The average cost of glaucoma drainage implants is approximately USD 2,000 per device, excluding post-operative care and surgery, which can exceed USD 11,000 per procedure.

Additionally, robot-assisted eye surgery is in trend that reduces human error and increases accuracy in glaucoma procedures. Now institutions like the University of California are testing robotic microsurgery for delicate ophthalmic operations. With continuous advancement in innovations and improvement in patient outcomes globally, the market for glaucoma drainage devices is anticipated to undergo a revolutionary shift in treatment modalities, further states the research report, “Global Glaucoma Drainage Devices Market Analysis, 2025”.

Global Glaucoma Drainage Devices Market Segmentation Analysis:

Hospitals are the Primary End-Users of Glaucoma Drainage Devices

Based on end users, the market is further bifurcated into Hospitals, Specialty Clinics, and Others. The hospital segment accounts for approximately 55% of the global market for glaucoma drainage devices. Due to their advanced clinical infrastructure, specialized equipment, and ability to perform challenging surgical procedures, hospitals continue to be the top-end users. The main healthcare locations for glaucoma surgeries and treatments are hospitals that have vast facilities. Due to the increasing incidence of glaucoma, particularly in older adults, the number of surgical procedures performed in health centers has increased. Because of the ongoing advancements in glaucoma surgery techniques and the integration of technology, hospitals now control a large portion of this market.

North America Leads the Glaucoma Drainage Devices Industry Globally

Geographically, North America commands 40% of the global market for glaucoma drainage devices, making it the dominant region. This dominance is due to the high prevalence of glaucoma in the area, especially among the elderly. A sophisticated healthcare infrastructure, well-established reimbursement procedures, and a high standard of medical care are all enjoyed in North America. The U.S. is an important market due to the rising use of advanced surgical methods, government initiatives to expand access to healthcare, and high patient awareness of the importance of early glaucoma detection and treatment. Moreover, the presence of leading manufacturers of glaucoma drainage devices and continuous research and development in the region has helped North America establish its position.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Johnson & Johnson, AbbVie Inc., Alcon Inc., Glaukos Corporation, NovaEye Medical Limited, iSTAR Medical, Rheon-medical, New World Medical Inc., Aurolab, Santen Pharmaceutical Co., Ltd., Advanced Ophthalmic Innovations Pte Ltd., and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?